Stock research log
$ASND Insider Trading
Ascendis Pharma A/S
3
Alerts Listed
0
Insider Buys 30d
0
Insider Sells 30d
This page is InsiderWatch’s research log for ASND: the alerts we sent on this stock, timestamped, plus recent insider buying and selling reported to the SEC on Form 4.
Price and Our Alerts
$ASND price
Daily closing prices
3M change
+5.6%
1Y high
$277.18
1Y low
$196.01
Our alerts
3
in this window
Prices from public market data and may be delayed. Markers show the days our alerts on this stock fired. Not investment advice.
Our Alerts on $ASND
| Sent (ET) | Call | Alert |
|---|---|---|
| Sep 19, 6:43 AM | NEUTRAL | Ascendis reclaims TransCon metabolic rights from Novo |
| Sep 14, 6:14 PM | NEUTRAL | Ascendis regains TransCon obesity, cardiometabolic rights |
| Aug 18, 9:03 PM | BULLISH | Ascendis director buys $493K, triples own stake |
Every alert we sent on ASND is listed after a short delay, in the order it went out. The call shown is the one in the alert as sent.
Recent Insider Activity
Open-market buys and sells in ASND by the company’s own officers, directors, and large holders, as reported to the SEC on Form 4 in roughly the last 30 days. New to the filing? Read what a Form 4 is and what the transaction codes mean.
| Filed (ET) | Insider | Action | Value |
|---|---|---|---|
| Sep 9 | Bodenhoff MadsSVP & PAO | SELL | $811k |
| Aug 18 | BIENAIME JEAN JACQUESDirector | BUY | $493k |
Sourced from public SEC Form 4 filings. Buys shown are open-market purchases; routine grants and plan sales are filtered out before a trade reaches this log.
See the research log across all stocks, this week’s insider buying, or the congress trading tracker.
Get the Next ASND Alert When It Fires.
Everything here is already public. Subscribers usually got it within minutes. Pro members get every alert. Free for 7 days, cancel any time.
Try Free for 7 DaysInsiderWatch is an informational research service based on publicly available information only and is not financial, investment, legal, or tax advice. The call shown is a reading of the event, not a recommendation to trade.